The Course and Correlates of Everyday Functioning in Schizophrenia - PubMed
- ️Wed Jan 01 2014
The Course and Correlates of Everyday Functioning in Schizophrenia
Abraham Reichenberg et al. Schizophr Res Cogn. 2014.
Abstract
Previously institutionalized older patients with schizophrenia show changes in cognitive and functional capacity over time. This study examined changes in real-world functioning in a sample of people with schizophrenia who varied in their history of long-term institutionalization and related changes in real world functioning to changes in cognition and functional capacity over the follow-up period. Older patients with schizophrenia (n=111) were examined with assessments of cognitive functioning, functional capacity, clinical symptoms, and everyday functioning. They were then followed up to 45 months and examined up to two times. Mixed-model regression was used to examine changes in real-world functioning in social, everyday living, and vocational domains over the follow-up period and identify potential predictors of change. Everyday functioning worsened over time in all three domains. Although length of longest hospitalization predicted worsening, this influence was eliminated when the course of functional capacity was used to predict the course of everyday functioning. For both vocational and everyday living domains, as well as the composite score on functional status, worsening in performance based measures of everyday functioning and social competence predicted worsening in real world functioning. Changes in negative symptoms further predicted worsening in the everyday living domain. Worsening in everyday functioning is found in people with schizophrenia and those with a history of greater chronicity and severity of illness seem more affected. These influences seem to be expressed through worsening in the ability to perform everyday functional skills. Potential causes of these changes and implications for reducing these impairments are discussed.
Figures
Similar articles
-
Harvey PD, Reichenberg A, Bowie CR, Patterson TL, Heaton RK. Harvey PD, et al. Biol Psychiatry. 2010 May 15;67(10):933-9. doi: 10.1016/j.biopsych.2010.01.008. Epub 2010 Mar 3. Biol Psychiatry. 2010. PMID: 20202624 Free PMC article.
-
Leifker FR, Bowie CR, Harvey PD. Leifker FR, et al. Schizophr Res. 2009 Nov;115(1):82-7. doi: 10.1016/j.schres.2009.09.004. Epub 2009 Sep 22. Schizophr Res. 2009. PMID: 19775869
-
Strassnig MT, Raykov T, O'Gorman C, Bowie CR, Sabbag S, Durand D, Patterson TL, Pinkham A, Penn DL, Harvey PD. Strassnig MT, et al. Schizophr Res. 2015 Jun;165(1):76-82. doi: 10.1016/j.schres.2015.03.033. Epub 2015 Apr 11. Schizophr Res. 2015. PMID: 25868935 Free PMC article.
-
Functional capacity: a new framework for the assessment of everyday functioning in schizophrenia.
Mantovani LM, Teixeira AL, Salgado JV. Mantovani LM, et al. Braz J Psychiatry. 2015 Jul-Sep;37(3):249-55. doi: 10.1590/1516-4446-2014-1551. Braz J Psychiatry. 2015. PMID: 26376057 Review.
-
Giuliani L, Giordano GM, Bucci P, Pezzella P, Brando F, Galderisi S. Giuliani L, et al. Front Psychiatry. 2021 Dec 14;12:791117. doi: 10.3389/fpsyt.2021.791117. eCollection 2021. Front Psychiatry. 2021. PMID: 34970172 Free PMC article. Review.
Cited by
-
Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance.
Molina V, Fernández-Linsenbarth I, Queipo-de-Llano M, Jiménez-Aparicio MT, Vallecillo-Adame C, Aremy-Gonzaga A, de-Andrés-Lobo C, Recio-Barbero M, Díez Á, Beño-Ruiz-de-la-Sierra RM, Martín-Gómez C, Sanz-Fuentenebro J. Molina V, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Sep;273(6):1379-1386. doi: 10.1007/s00406-022-01518-1. Epub 2022 Nov 22. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36416961 Free PMC article.
-
Fett AJ, Velthorst E, Reichenberg A, Ruggero CJ, Callahan JL, Fochtmann LJ, Carlson GA, Perlman G, Bromet EJ, Kotov R. Fett AJ, et al. JAMA Psychiatry. 2020 Apr 1;77(4):387-396. doi: 10.1001/jamapsychiatry.2019.3993. JAMA Psychiatry. 2020. PMID: 31825511 Free PMC article.
-
Kalisova L, Michalec J, Dechterenko F, Silhan P, Hyza M, Chlebovcova M, Brenova M, Bezdicek O. Kalisova L, et al. Schizophrenia (Heidelb). 2023 Jul 17;9(1):43. doi: 10.1038/s41537-023-00374-9. Schizophrenia (Heidelb). 2023. PMID: 37460587 Free PMC article.
-
Reckziegel R, Czepielewski LS, Hasse-Sousa M, Martins DS, de Britto MJ, Lapa CO, Schwartzhaupt AW, Gama CS. Reckziegel R, et al. Braz J Psychiatry. 2022 Jan-Feb;44(1):74-80. doi: 10.1590/1516-4446-2020-1670. Braz J Psychiatry. 2022. PMID: 33886948 Free PMC article. Review.
-
Helldin L, Mohn C, Olsson AK, Hjärthag F. Helldin L, et al. Schizophr Res Cogn. 2020 Feb 14;20:100172. doi: 10.1016/j.scog.2020.100172. eCollection 2020 Jun. Schizophr Res Cogn. 2020. PMID: 32090024 Free PMC article.
References
-
- Andreasen NC, Flaum M, Arndt S. The comprehensive assessment of symptoms and history (CASH): An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry. 1992;49:615–623. - PubMed
-
- Beck A, Steer R, Brown G. BDI-II, The Beck Depression Inventory Second Edition. The Psychological Corporation; San Antonio, TX.: 1996.
-
- Buchanan RW, Davis M, Goff D, Green MF, Keefe RSE, Leon AC, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005;31:5–19. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources